novel
sever
acut
respiratori
syndrom
corona
viru
caus
coronaviru
result
global
pandem
unpreced
impact
medic
resourc
personnel
patient
care
access
issu
given
eas
hosthost
transmiss
impact
medic
resourc
much
world
implement
physic
distanc
restrict
appropri
leav
home
reduc
transmiss
subsequ
strain
medic
resourc
suggest
patient
cancer
may
wors
respiratori
outcom
patient
without
cancer
howev
data
preliminari
given
constantli
evolv
challeng
surround
potenti
impact
healthcar
review
amass
evid
help
guid
manag
time
brachytherapi
gynecolog
breast
prostat
cancer
concret
data
could
found
peerreview
expert
opinion
provid
importantli
recommend
appli
patient
known
infect
patient
symptom
concern
alreadi
test
posit
recommend
follow
local
clinic
andor
hospit
treatment
polici
procedur
given
uniqu
resourc
institut
delay
treatment
neg
test
may
indic
order
protect
patient
treat
team
maintain
access
care
patient
treat
facil
given
purpos
follow
commentari
seroma
caviti
therefor
fall
line
time
extern
beam
patient
dci
radiat
safe
delay
week
follow
breast
conserv
surgeri
patient
invas
diseas
mix
data
regard
time
adjuv
treatment
studi
show
rt
treatment
delay
week
follow
bc
associ
inferior
local
control
larg
systemat
review
studi
show
local
recurr
rate
significantli
higher
patient
receiv
adjuv
rt
week
surgeri
compar
treat
within
week
ci
studi
shown
interv
week
may
safe
detriment
local
control
overal
surviv
os
patient
without
advers
tumor
control
surviv
outcom
conflict
data
regard
whether
postpon
treatment
diagnosi
lead
wors
outcom
prostat
cancer
surgeri
like
retrospect
natur
studi
heterogen
patient
group
play
larg
role
variabl
find
largest
studi
involv
surgeri
examin
prostatectomi
patient
underw
surgeri
within
one
year
diagnosi
found
impact
time
biopsi
surgeri
biochem
recurr
mean
followup
year
remain
true
even
examin
subset
higher
risk
patient
similarli
largest
studi
rt
examin
patient
underw
ebrt
alon
found
differ
os
causespecif
surviv
css
distant
metastasi
dm
freedom
biochem
failur
ffbf
base
time
treatment
month
diagnosi
also
found
differ
ffbf
dm
highrisk
patient
base
studi
other
safe
interv
postpon
definit
treatment
may
month
even
true
detriment
cancer
outcom
postpon
therapi
fulli
captur
studi
conflict
data
suggest
small
magnitud
must
weigh
risk
pose
patient
societi
pandem
overal
unlik
postpon
month
unlik
significantli
impact
diseas
outcom
like
true
grade
group
cancer
due
indol
rate
growth
highergrad
cancer
due
efficaci
androgen
depriv
therapi
adt
tradit
two
month
neoadjuv
adt
given
prior
rt
although
recent
evid
suggest
necessari
howev
set
attempt
reduc
patient
exposur
neoadjuv
adt
may
given
mani
month
possibl
longer
prior
definit
therapi
given
excel
equival
result
seen
studi
use
approach
use
brachytherapi
treatment
prostat
cancer
typic
definit
treatment
data
suggest
two
fraction
may
result
decreas
tumor
control
interstiti
cervic
hdr
brachytherapi
ab
recommend
singl
implant
five
treatment
deliv
twice
daili
minimum
hour
separ
fraction
altern
deliveri
five
fraction
singl
hospit
feasibl
deliveri
gy
twice
per
day
separ
hour
interv
perform
twice
two
separ
implant
consecut
week
also
found
effect
variou
fraction
option
shown
tabl
tumor
distal
vagin
extens
involv
smaller
fraction
size
addit
fraction
may
necessari
may
minim
risk
highgrad
toxic
dose
organ
risk
oar
earli
stage
uterin
cancer
adjuv
vagin
cuff
monotherapi
use
hdr
brachytherapi
three
six
fraction
common
set
minim
patient
exposur
risk
imper
use
gy
x
fraction
depth
dose
cm
common
safe
howev
select
patient
anatomi
requir
cylind
size
mm
consider
four
five
fraction
regimen
may
help
prevent
excess
vagin
dose
late
toxic
tabl
women
breast
cancer
treat
breast
conserv
surgeri
apbi
option
tabl
entri
intracavitari
devic
easier
place
time
surgeri
within
week
thereaft
surgic
cavityseroma
identifi
multicathet
interstiti
implant
strictli
reli
implant
surgic
caviti
therefor
perform
immedi
follow
surgeri
later
triumpht
trial
gy
x
fraction
apbi
women
treat
breast
conserv
surgeri
tumor
cm
show
low
toxic
excel
cosmet
outcom
good
local
control
fraction
option
includ
gy
deliv
fraction
given
twice
per
day
rtog
gy
deliv
fraction
given
twice
per
day
gy
x
fraction
prefer
gy
x
fraction
inferior
bt
definit
boost
offer
shorter
overal
treatment
cours
convent
moder
hypofraction
ebrt
brachytherapi
practition
consid
resourc
limit
access
person
protect
equip
limit
personnel
limit
physic
space
etc
may
prevent
delay
bt
deliveri
given
consider
note
stereotact
abl
radiat
sabr
safe
effect
treatment
patient
risk
categori
deliv
fraction
patient
receiv
gener
analgesia
individu
anesthesia
plan
develop
preprocedur
evalu
requir
better
understand
minim
patient
risk
ongo
involv
anesthesiolog
strongli
encourag
input
valuabl
physician
without
moder
sedat
experi
open
commun
team
member
necessari
minim
risk
aerosol
particl
brachytherapi
procedur
review
patientand
casespecif
factor
felt
intub
ventil
necessari
strong
consider
given
anesthesia
staff
room
intub
extub
awar
ventil
filter
system
import
particularli
viral
filtrat
effici
use
breath
system
filter
strong
consider
given
effici
particul
air
hepa
filter
system
ventil
system
patient
disconnect
system
patient
ventil
avoid
furthermor
similar
patient
tuberculosi
consid
implement
wait
period
prior
staff
reentri
room
follow
extub
howev
studi
coronaviru
knowledg
final
earli
report
show
patient
may
experi
endotheli
damag
sever
coagulopathi
andor
thromboembol
patient
also
requir
brachytherapi
implant
plan
overnight
hospit
immobil
strong
consider
given
need
therapeut
anticoagul
andor
augment
implant
techniqu
necessari
plan
mri
obtain
smit
sleev
place
fusion
mri
subsequ
base
brachytherapi
implant
coregist
smit
sleev
third
strategi
cognit
fusion
treat
physician
contour
ct
applic
place
directli
refer
brachytherapi
mri
may
also
aid
defin
hrctv
time
resourc
effici
manner
integr
mri
optim
encourag
manner
note
logist
barrier
exist
prevent
may
potenti
worsen
ct
base
volumetr
brachytherapi
plan
remain
highli
access
method
reduc
toxic
improv
diseas
control
compar
film
base
point
plan
tempor
option
endocrin
therapi
exist
patient
wish
avoid
tradit
treatment
paradigm
decreas
risk
endometrioid
precancer
lesion
aris
prolong
exposur
endometrium
estrogen
progestin
act
inhibit
endometri
prolifer
use
manag
low
risk
surgic
inoper
women
endometri
cancer
agent
continu
month
reassess
respons
everi
month
month
complet
respons
definit
surgeri
pursu
breast
andor
prostat
cancer
delay
definit
adjuv
therapi
may
also
possibl
use
endocrin
therapi
tempor
measur
patient
gynecolog
breast
prostat
cancer
tempor
therapi
availableappropri
brachytherapi
treatment
indic
consid
prioriti
deem
critic
therapi
requir
servicestreat
due
clinic
situat
delay
omiss
therapi
result
sever
neg
impact
oncolog
outcom
life
expect
delay
anticip
treat
physician
make
altern
plan
earli
possibl
consid
referr
necessari
anoth
facil
equip
staf
deliv
treatment
minim
disrupt
treatment
timelin
mani
potenti
reason
treatment
delay
beyond
physiciancentr
issu
tabl
impact
staff
shortag
lack
social
worker
ancillari
support
hous
transport
socioeconom
factor
loss
job
hous
insur
may
play
role
tabl
factor
affect
time
deliveri
treatment
coordin
care
among
differ
site
multidisciplinari
coordin
care
poor
patient
navig
system
patient
factor
ie
ill
socioeconom
challeng
transport
institut
factor
ie
staf
shortag
equip
shortag
medic
shortag
tabl
factor
affect
time
deliveri
treatment
factor
like
concern
pandem
hospit
servic
personnel
impact
import
recogn
strategi
may
mitig
lessen
impact
delay
treatment
tabl
line
strategi
ab
astro
recent
issu
recommend
set
outlin
section
reduc
patient
exposur
resourc
util
import
critic
maintain
brachytherapi
servic
patient
furthermor
use
brachytherapi
may
shorten
treatment
time
exposur
patient
tabl
strategi
preserv
cancer
care
minim
risk
use
alter
fraction
schedul
endocrin
therapi
tempor
measur
breast
prostat
uterin
cancer
appropri
elimin
consolid
nonessenti
procedur
modifi
gener
anesthesia
protocol
switch
neuraxi
sedat
andor
moder
sedat
local
analgesia
streamlin
staf
minim
personnel
exposur
incorpor
telemedicin
feasibl
